TABLE 3.
Initial Diagnosis and Follow-Up (Time of Recurrence for the Recurrence Group) Data for the Groups
| Initial (N =120)
|
Follow-up (N = 120)
|
|||
|---|---|---|---|---|
| Disease Free
(n = 90) |
Recurrence
(n = 30) |
Disease Free
(n = 90) |
Recurrence
(n = 30) |
|
| Variables | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) |
| Cancer Specific Stress | ||||
| Impact of Events Scalea | 25.75 (14.02)a | 23.28 (12.94)a | 12.35 (11.98)b | 21.01 (13.74)a |
| QoL: Distress and Mental Health | ||||
| Profile of Mood States | 20.78 (21.61) | 27.83 (18.89) | 12.02 (21.85) | 19.92 (21.47) |
| CES-D | 5.48 (3.62) | 6.10 (3.57) | 3.88 (3.56) | 5.83 (4.46) |
| SF-36 MHCS | 43.40 (11.35) | 41.95 (11.14) | 51.99 (8.20) | 46.61 (9.11) |
| QoL: Social Adjustment | ||||
| Social Network Index | 6.70 (2.69) | 5.83 (2.98) | 6.34 (2.95) | 6.31 (2.71) |
| Perceived Social Support | ||||
| Family | 16.74 (4.07) | 17.34 (3.98) | 17.22 (3.59) | 18.03 (3.92) |
| Friends | 17.54 (3.05) | 16.31 (3.31) | 17.54 (2.89) | 17.19 (3.53) |
| Dyadic Satisfactiona | 4.07 (1.08)a | 3.68 (1.29)a,b | 3.53 (1.37)b,c | 3.86 (1.21)a,b |
| Functional Status and Health Evaluationa | ||||
| Karnofsky Performancea | 85.80a (7.98) | 82.00 (9.61)b | 90.45 (5.85)c | 78.00 (9.61)d |
| SWOGa | 0.20a (0.11) | 0.22a (0.11) | 0.25 (0.10)b | 0.27 (0.11)b |
| SF-36 PFCSa | 40.59a (6.61) | 40.54a (6.49) | 48.21 (10.07)b | 39.41 (9.47)a |
SD: standard deviation; CES-D: Center for Epidemiologic Studies-Depression Scale; SF-36: Medical Outcomes Study Short Form; MHCS: Mental Health Component Score; SWOG: Symptoms, signs, and illnesses measure from the Southwest Oncology Group; PFCS: Physical Functioning Component Score.
a
P < 0.05 for M/ANOVA. For measures with significant group by time interactions, common superscripts indicate no significant differences between means, whereas different superscripts indicate significant differences (P < 0.05).